Xcout IntelVectivBio
VectivBio was a Swiss clinical-stage biopharmaceutical company focused on developing therapies for severe gastrointestinal and rare diseases. Its lead asset, apraglutide, was…
The full profile of VectivBio
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see VectivBio →Already a subscriber? Sign in
Xcout Intel tracks VectivBio continuously — this profile deepens as new filings, funding, people and hiring data arrive.